AMENDOLARA, ROCCO
 Distribuzione geografica
Continente #
EU - Europa 125
NA - Nord America 55
AS - Asia 50
SA - Sud America 6
AF - Africa 1
Totale 237
Nazione #
IT - Italia 93
US - Stati Uniti d'America 55
SG - Singapore 36
UA - Ucraina 8
IN - India 6
FR - Francia 5
BR - Brasile 4
ID - Indonesia 4
MY - Malesia 4
SE - Svezia 4
AR - Argentina 2
AT - Austria 2
DE - Germania 2
DK - Danimarca 2
ES - Italia 2
FI - Finlandia 2
BE - Belgio 1
BG - Bulgaria 1
IE - Irlanda 1
LU - Lussemburgo 1
RU - Federazione Russa 1
ZA - Sudafrica 1
Totale 237
Città #
Rome 52
Singapore 27
Santa Clara 10
Chandler 7
Boardman 5
Jakarta 4
Belo Horizonte 3
Molfetta 3
Bedong 2
Copenhagen 2
Dallas 2
Fontanellato 2
Innsbruck 2
Ipoh 2
Madrid 2
Messina 2
Milan 2
Munich 2
Naples 2
Pagani 2
San Diego 2
San Paolo di Civitate 2
Santarcangelo di Romagna 2
Seattle 2
Vicente López 2
Ashburn 1
Brussels 1
Chieti 1
Dublin 1
Fairfield 1
Fonte Nuova 1
Fremont 1
Helsinki 1
Hyderabad 1
Johannesburg 1
Lappeenranta 1
Lawrence 1
Luxembourg 1
Millbury 1
Moscow 1
Paris 1
Princeton 1
Shimla 1
Sofia 1
São Paulo 1
Wilmington 1
Totale 166
Nome #
Impact of cardiovascular disease on clinical outcomes in hospitalized patients with Covid-19. a systematic review and meta-analysis 88
Association of osteocalcin, osteoprotegerin, and osteopontin with cardiovascular disease and retinopathy in type 2 diabetes 56
Reduced early response to SARS-CoV2 vaccination in people with type 1 and type 2 diabetes, a six months follow-up study. The CoVaDiab study I 29
Immune checkpoint modulators in early clinical development for the treatment of type 1 diabetes 27
Saxagliptin/dapagliflozin is non‐inferior to insulin glargine in terms of β‐cell function in subjects with latent autoimmune diabetes in adults: a 12‐month, randomized, comparator‐controlled pilot study 27
Lack of Association between Serum Chitotriosidase Activity and Arterial Stiffness in Type 2 Diabetes without Cardiovascular Complications 19
No differences in kidney function decline between people with type 2 diabetes starting a sodium-glucose cotransporter 2 inhibitor or a glucagon-like peptide-1 receptor agonist: a real-world retrospective comparative observational study 17
Totale 263
Categoria #
all - tutte 1.056
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.056


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202238 0 0 0 22 1 2 2 2 4 0 3 2
2022/202346 3 3 2 5 2 6 1 2 4 9 6 3
2023/202493 5 3 2 7 13 7 11 4 2 10 7 22
2024/202586 14 23 6 30 13 0 0 0 0 0 0 0
Totale 263